Physician profile
William E Nordt
NPI 1780694760
$2,566,189.74
in general payments reported to CMS, 2019-2025
11 companies · $449K in 2025
The $449K reported for 2025 was more than what 99% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373K · 2020: $351K · 2021: $370K · 2022: $337K · 2023: $381K · 2024: $305K · 2025: $449K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.1M · Food and Beverage: $2,022 · Consulting Fee: $930 · Travel and Lodging: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,131,501.72 |
| Food and Beverage | $2,021.50 |
| Consulting Fee | $930.00 |
| Travel and Lodging | $760.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $2,556,021.72 | 2019-2025 | Donjoy, Procare, Aircast |
| Stryker Corporation | $3,501.05 | 2019-2023 | Mako, Triathlon, Tritanium |
| Medical Device Business Services, INC. | $2,635.22 | 2019-2024 | Attune |
| Arthrex, INC. | $1,907.00 | 2019 | |
| Depuy Synthes Sales INC. | $847.85 | 2019-2025 | Attune, Velys, Monovisc |
| Fortis Surgical, LLC | $600.39 | 2019 | |
| Smith+Nephew, INC. | $469.38 | 2019-2025 | Real Intelligence |
| Zimmer Biomet Holdings, INC. | $145.44 | 2025 | Rosa |
| Cartiheal (2009) Ltd. | $61.69 | 2023 | Agili-C |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Nordt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.